PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Protocols List Clinical Research Program .pdf



Original filename: Protocols List - Clinical Research Program.pdf

This PDF 1.6 document has been generated by PDF24 Creator / Adobe Acrobat Pro 11.0.5 Paper Capture Plug-in, and has been sent on pdf-archive.com on 09/09/2016 at 16:39, from IP address 212.110.x.x. The current document download page has been viewed 2538 times.
File size: 5.2 MB (58 pages).
Privacy: public file




Download original PDF file









Document preview


PDF.Jsvla.ver

9/M016

~McGill
Gerald Bronfman Centre for Clinical Research in Oncology
Clinical Research Program
546 Pine Avenue West

Mont real, Quebec H2W 1S6
- McGill Studies List Period of January 2000 to Present
-McG 0001[CZOL446 0702]
A Randomized, Placebo-Cont rolled Study on the Efficacy and Tolerability of Zometa in t he Prevention of Disease
Recurrence in Pat ients w it h Node Posit ive Primary Breast Cancer
Novartis
WITHDRAWN BY COMPANY
Dr. L. Panasci
-McG 0002[CA99002]
Pivot al Phase II Multicen t er Study ofVincristine Sulfa t e Liposomes Injection in Diffuse Large B-Cell Non-Hodgkin's
Lymphoma at Second or Lat er Relapse

lnex
Dr. S. Caplan

TERM INATED

-McG 0003-

[195-301]
Phase 111, Randomized, M ulticenter St udy to Assess t he Efficacy and Safety of HuM 195 (Recombinant Human ized AntiCD33 Monoclonal An ti body) in Combination w ith Sta ndardized Chemot herapy Compared to Standardized
Chemotherapy Alone in t he Treatm ent of Patients W ith Refract ory or First-Relapsed Acute Myelogenous Leukemia
(AML)
WITHDRAWN BY COMPANY
Theradex
Dr. P. Laneuville
-McG 0004[R115777-INT-11]
A Phase Ill Double-Blind, Placebo Controlled Trial of Gemcitabine Plus Placebo vs. Gemcit abine Plus R115777 in
Chemonaive Patient s w it h Ad vanced Pancreatic Cancer
Janssen-Ortho
Dr. A. Langleben/Beverly DeSalis
TERM INATED
-McG 0005[T99-0046]
M ult icenter, Open-Ended, Double-Blind, Placebo -Cont rolled, Phase Ill Study of AE-941 in Addition t o Combined

Modality Tre atmen t (Chemot herapy/ Radiotherapy) For Locally Ad vanced Unresect able Non -Small Cel l Lung Cancer
Aet erna
TERM INATED
Dr. G.Batist/Ginette Ricard
-McG 0006[PR96-27-031]
The Effects of PROCRIT (Epoetin alfa) on Hemoglobin, Symptom Dist ress and Quality of Life During Chemot herapy in
Lymphoma, Chronic Lymphocyt ic Leukemi a or M ultiple Myeloma Patient s wit h Mild to Moderate Anemi a
Ort ho Biotech
WITHDRAWN
Dr. C. Shustik

Active= Open to Enrollment
Closed= Closed to Enrollment
Termin ated= Study Terminated with IRB/ Information no longer required

Revised: 2/6/2016

Parentheses indicate Principal ln\·estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am

1J58

PDF.Jsvla.ver

9/M016

Page 2 of 58
McG Studies

-McG 0007-

[M39021]

An Open-Label, Ran domized, M ulti-Center, Phase Ill Trial Comparing CVP + MabThera to Standard CVP Chemotherapy
in Patients w ith Previously Untrea te d CD20 Positive Follicular Lymphoma (Stage Ill-IV)
Hoffman-LaRoche
CLOSED
Dr. C. Shustik

-McG 0008-

[RSR13 RT-009)

A Phase 3 Randomi zed, Open-Label, Comparative Study of Sta ndard Whole Brain Radiation Thera py w ith or without
RSR13 in Patients with Brain M etastases
Allos Thera peutics
TERM INATED
Dr. K. Sulta nem

-McG 0009-

(104864/552)

A Phase 11, M ult icenter, Open-Label Study of Oral Topotecan and Cisplatin in Ovarian Cancer Recurring Ill 6 Months
Following Initial Plat inum-Based Chemotherapy
SmithKline Beecham
TERM INATED
(Dr. M. Trudeau) (Dr. A. Langleben) Dr. G. Stanimir

-McG 0010-

(98-6475-183)

A Ran domized, Open-Label, M ulticenter, Phase Ill Study St udy Comparing t he Efficacy and Safety of Gemcitabine and
lrenotecan HCI (CPT-11) to t he Gemcita bine Alon e in Patients w ith Locally Advanced or Metastatic Pancreat ic Cancer
who Have Not Received Prior Systemic Therapy
Pharmacia
TERM INATED
(Dr. Trudeau ) (Dr. A. La ngleben) Dr. W. Miller

-McG 0011-

[CSTl571 0106) "I RIS"

A Phase Ill Study of STl571 Versus Interferon-a (IFN-a) Combined wit h Cytarabine (ARA-C) in Pat ients wit h Newly
Diagnosed Previously Unt reat ed Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic
Phase (CM L-CP)
Novartis
CLOSED
Dr. C. Shustik

-McG OOUE-

[STl571 0106 Extension]

An Exten sion Protocol for Patients who Progress to Accelerated Phase or Blast Crisis on t he INF-a+ Ara -C Treatment
Arm of t he Core Pro t ocol
Novartis
CLOSED
Dr. C. Shustik

-McG 0012-

[H4Z-MC-JWXD]

Phase 3 Ran domized Double-Blind Evaluation of LY353381 Compared wit h Tamoxifen in Women with Locally
Ad vanced or Metastatic Breast Cancer
Eli Lilly
TERM INATED
Dr. L. Pa nasci

-McG 0013-

[N91-00-02-040]

A Ran domized, Double-Blind, Placebo Contro lled Comparison of t he Analgesic Acti vity of Va ldecoxib (SC-65872) 40mg
BID as Add -on Therapy to Opioid Medication in Patient s w ith Chronic Cancer Pain
Searle
TERM INATED
Dr. B. Gagnon

Active= Open to Enrolhnent

Revised:

2/6/2016
WB

Closed= Closed to Enrolhnent
Terminated= Study Terminated w ith IRB/ hlformation no longer required
Parentheses indicate Principal Im·estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am

PDF.Jsvla.ver

9/M016

Page 3 of 58
McG Studies

-M cG 0014[-]
Phase II M ulticenter Trial wit h Gemcitabine and Docetaxel in Patients wit h Ad vanced (Stage lll B +IV) Non -Small Cell
Lung Cancer
Aventis Pharma
TERM INATED
Dr. V. Hirsh
-M cG 0015(1164.4)
A Phase 111, Double-Blind, Randomized, Placebo-Controlled Study of Porfiromycin Used as an Adjuvant to Radiation
Therapy in Postope·ra t ive Head and Neck Cancer Pat ients
WITHDRAWN
Boehri nger lngelhei m
-M cG 0016(9902)
A Phase Ill M ult icenter, Randomized, Open-Label Trial Evaluating High Dose Melphalan plus Holmium-166-DOTM P
versus High Dose Melphalan Alone w hen Given in Conj unction w ith Peripheral Blood St em Cell Transplantation in
Pat ients w ith Multi pie Myeloma
NeoRx Corporati on
Dr. C. Shustik
INVESTIGATOR W ITH DRAWN
-M cG 0017[18391L/0017]
A Ran domized, Double-Blind, Phase Ill Comparative Trial of 2 Doses of ZD 1839 (IRESSA™) in Combi nation with
Paclitaxel and Carboplatin versus Placebo in Combination with Paclitaxel and Carboplatin i n Chemot herapy-Na.Ive
Pat ients w ith Ad vanced (Stage Ill or IV) Non-Small Cell Lu ng Cancer
Ast raZeneca
TERM INATED
Dr. V. Hirsh
-M cG 0018[W016229]
A Phase II Study of Hercepti n Monot herapy Administered 3 Weekly in Women with HER2
Overexpression/Amplificat ion in M eta static Breast Cancer
Hoffmann La-Roche
Dr. L. Panasci

TERM INATED

-M cG 0019[MEL06199]
A Phase I Study of Heterologous Pri me-Boost Immunization by Intranodal or Subcut aneous Administration w ith
Recombinant Canarypox Virus Expressing Tumour Antigen gplOO (Modifi ed ) Fol lowed by Modified gplOO Pept ide
Combination in M elanoma
Aventis Past eur M erieux Connaught
TERM INATED
Dr. S. Burdette-Radoux
-M cG 0020[GN301]
Randomized Study of Dacarbazine Versus Dacarbazine Pl us G3139 (Bcl-2 An tisense Oligonucleotide) in Patients w ith
Ad vanced Malignant Melanoma
Genta Incorporated
TERM INATED
Dr. W. Miller
-M cG 0020ext- [GM214]
Continuation Protocol for Genasense (G3139, Bcl-2 Antisense Oligonucleot ide) and Dacarbazine in Patient s w ith
Malignant Melanoma Who to Responded to t his Combination in GM301
Genta Incorporated
TERM INATED
Dr. W. Miller

Active= Open to Enrolhnent

Revised:

2/6/2016
WB

Closed= Closed to Enrolhnent
Terminated= Study Terminated w ith IRB/ Information no longer required
Parentheses indicate Principal ln\·estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am

3158

PDF.Jsvla.ver

9/M016

Page 4 of 58
McG Studies

-M cG 0021[PRl/EPO-INT-76/EPO-CA-489]
A Dou ble-Blind, Ran domized, Placebo-Controlled St udy to Evaluate t he Impact of Maintai ning Hemoglobin Using
EPREX® (Epoetin Alpha; RWJPRl -22512) in M etasta t ic Breast Carci noma Subjects Receivin g Chemotherapy
Janssen-Ortho
TERM INATED
Dr. M. Thirlwell
-M cG 0022[EPO CAN 20]
Rand omized Trial of Epoetin Alph a in Patients with Advanced Non-Small Cell Carcinoma of t he Lung
OCOG
TERM INATED

Dr. B. Gagnon/M ary Ann Tasca
-M cG 0023[VIN20009]
A Phase II M ult i-Centre Trial of Sequential Therapy with Vinorelbine and Gemcitabine in Patient s w ith St age lll B +IV
Non-Small Cell Lu ng Ca ncer (NSCLC) w ith Emphasis on t he Elderly and Frail
CLOSED
Glaxo Wellcome
Dr. Vera Hirsh
-M cG 0024(20010116]
A Phase 3 Clinical Trial of lmmunot herapy with Human ized LL2 lgG (AMG 412) in Subjects w ith Low -Grade, Follicular,
B-cell Non-Hodgkin's Lymphoma Refract ory to Rituxan® (rit uximab)
Amgen
TERM INATED
Dr. C. Shustik
-McG 0101[CSTl571 0113]
An Expanded Access Prot ocol of STl571 in Patients with Chronic Myeloid Leukemia Who Are Hematologically or
Cytogenetically Resi stan t or Refractory t o Interf eron -Alpha, or Intolerant of, Interferon-Alpha
Novartis
TERM INATED
Dr. C. Shustik
-M cG 0102[CSTl571 0114]
An Expa nded Access Prot ocol of STl571 in Adult Patients with Either Chronic Myeloid Leu kemia in Accelerated Phase
or Philadelphia Ch romosome-Positive Acute Lymphoblast ic Leukemia
Novartis
TERM INATED
-M cG 0103[CSTl571 0115]
An Open-Label, Mu lt icenter Expanded Access Study of STl571 in Patient s with Either Chronic Myeloid Leukemia in
Myeloid o r Lymphoid Blast Crisis, or Philadelphia Chromosome-Positive Acute Myelogenous Leukemia
Novartis
TERM INATED
Dr. C. Shustik
-M cG 0104[BCH-4556-214]
A Phase II Study of Troxatyl in Patient s w it h CML Blastic Phase Disease
BioChem Pharma, Inc.
Dr. P. Laneuville

Active= Open to Enrolhnent

COMPANY WITHDRAWN

Revised:

2/6/2016
WB

Closed= Closed to Enrollment
Terminated= Study Terminated with IRB/ hlformation no longer required
Parentheses indicate Principal Im·estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am

PDF.Jsvla.ver

9/M016

Page 5 of 58
McG Studies

-McG 0105[}C-MM-00-02]
Neovastat (JE-94 1) in Refractory and Early Relapse M ultiple Myeloma Patients
tEtern a Laboratories, Inc.
Dr. C. Shustik

TERM INATED

-McG 0106[H 3E-MC-JM El(a)]
A Phase 3 Tr ial of ALIMTA vs Docetaxel in Patients w ith Locally Advanced or Metastatic Non-Small Cell Lung Cancer
(NSCLC) W ho Were Previously Treated wit h Chemotherapy
Eli Lilly
Dr. V. Hirsh/ Sylvie Beaudoin
TERM INATED
-McG 0107(104864/557]
A Phase II Trial of Topoteca n and Cisplatin in Patients wit h Metastatic or Recurrent Squamous Cell Carci noma of t he
Cervix
Smit hKline Beecham
(Dr. M. Trudeau) (Dr. A. Langleben) Dr. L. Souhami

TERM INATED

-McG 0108[CA163-013]
A Phase II Study of Epothilone Analog BMS-2 47550 in Patients wit h Metastatic Gastric Ad enocarcinoma Previously
Treated w ith a Fluoropyrimidine and/ or a Platinum
Bristol-Myers Sq uibb
Dr. A. Langleben

TERM INATED

-McG 0108-BC
[CA163-022]
A Protoco l to Collect Blood Samples for Pharmacogenomic Research from Patients Enrolled in a Clinical Trial of BMS247550 Epoth ilone B Analog.
Bristol-Myers Sq uibb
Dr. A. Langleben
W ITHDRAWN BY COMPANY
-McG 0108-TC
[CA163-016]
A Protoco l to Collect a Tu mour Tissue Sample for Pharmacoge nomic Research from Patients Enrolled in a Cl inical Trial
of BMS-247550 Epothilone B Analog.
Bristol-Myers Sq uibb
Dr. A. Langleben

W ITHDRAWN BY COMPANY

-McG 0109(401.00.001]
An Open La bel, Ra ndomized, Controlled, Phase Ill, Mult i-center, Clinical Trial of PN401 with High Dose 5-Fluorouracil
(5FU) versus Gemcitabine for Treatment of Patient s w ith Ad vanced Pancreatic Cancer
Pro-Neu ron, Inc.
TERM INATED
Dr. W. M iller
-McG 0110[B9E-CA-0312]
Phase I/ II Multi centter Trial w ith Carboplat in and Gemcitabine Induct ion Chemot herapy, Fo llow ed by Radiotherapy
Concomitantly wit h Low -Dose W eekly Paclitaxel and Gemcitabine for Patients wit h Stage llllA + B Non-Small Cell Lung
Ca ncer
Eli Lilly
Dr. V. Hirsh & Dr. M . Duclos
CLOSED

Active= Open to Enrolhnent

Revised:

2/6/2016
WB

Closed= Closed to Enrollment
Terminated= Study Terminated w ith IRB/ Information no longer required
Parentheses indicate Principal ln\·estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am

5158

PDF.Jsvla.ver

9/M016

Page 6 of 58
McG Studies

-M cG 0111[TH9402/l I/NH L/002)
Autologous TH9402 Pu rged Progenitor Cell transplantation for Non-Hodgki n's Lymphoma
Theratechnologies li ne.
Dr. P. Laneuville

TERM INATED

-M cG 0112[EPO-CAN-15)
A Ran domized, Double-Blind, Placebo-Control led St udy to Evaluate t he Impact of Maintai ning Haemoglobin Levels
Usi ng EPREX* / PROCRIT® (Epoetin alfa) in Limited Disease Small Cell Lung Ca ncer (LD SCLC) Subjects Receiving
Combined Chemot herapy and Radiation Therapy.
Ort ho Biotech Inc.
TERM INATED
Dr. V. Hirsh
-M cG 0113[GMY302]
Rand omized Phase Ill Stu dy of Dexamethasone With o r Wi t hout Genasense™ 9Bcl-2 Antisense Oligonucleoti de) in
Patients w ith Relapsed or Refractory Multiple M yeloma

Genta
Dr. C. Shustik

TERM INATED

-M cG 0114[RPI0003]
A Phase II, Open-Label, Multi-Center Trial of Angiozyme in Combination w ith 5-FU, Leucovorin and lrinotecan in
Subjects w ith Metastat ic Colorectal Cancer
Ribozyme Pharmaceuticals
TERM INATED
Dr. W. Miller
-M cG 0114ext[RPI0102]
A Phase 11, Open-Label, Multicenter Trial of Angiozyme in Subjects W ith M etastatic Colorectal Cancer Who Have
Completed RPI0003
Ribozyme Pharmaceuticals
TERM INATED
Dr. W. Miller
-M cG 0115[EFC4585]
A Multicenter, Ope n-label, Rand omized, Tw o-Arm St udy of lrinotecan (CPT-11) Versus t he Combination of Oxaliplati n
+ lrinot ecan (CPT-11) as Second-Line Treatment of Metastatic Colorectal Carcinoma
Sanofi-Synthelabo
TERM INATED
Dr. W. Miller
-M cG 0116[88951A-PRT031
A Ran domized, Open-Label, M ulticenter Phase Il l Study Comparing th e Efficacy and Safety of a Combination of
Intravenous DX-895lf (Exatecan Mesylate) Plus Gemcitabine t o Gemcitabine Alone in Patients wit h Locally Ad vanced
or Metastat ic Cancer of t he Exocri ne Pancreas Who Have Not Received Prior Chemotherapy
Daiichi
TERM INATED
Dr. M. Thirlwell
-M cG 0117[R115777-INT-17]
A Phase 2 Study Eva luating t he Efficacy of th e Farnesyl Transfe rase Inhibitor (FTI) R115777 in Patients w ith Refractory
or Elapsed Acute Myeloid Leukemia (AML)
Janssen Re search Fdn.
TERM INATED
Dr. C. Shustik

Active= Open to Enrolhnent

Revised:

2/6/2016
WB

Closed= Closed to Enrolhnent
Terminated= Study Terminated w ith IRB/ Information no longer required
Parentheses indicate Principal ln\·estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am

6158

PDF.Jsvla.ver

9/M016

Page 7 of 58
McG Studies

-M cG 0118[COL14]
Pilot Phase II Stu dy of Safety and lmmunogenicity of an Al vac-CEA/ B7.1 Vaccine Administered Eit her Subcuta neously
or lntranodally, Concurrently w ith Chemothera py, in Patients wit h Metastatic Colorectal Adenocarcinoma.
Aventis
Dr. A. Langleben
WITHDRAWN BY COMPANY
-M cG 0119[EFC 4584]
A Multicenter, Ope n-Label, Randomized, Three-Arm Study of 4-Fluorouracil (5-FU) Plus Leucovorin (LV) or Oxa liplati n
or a Combination o r 5-FU/LV + Oxaliplatin as Second-Li ne Treat ment of M etastat ic Colorect al Carcinoma.
TERM INATED
Sanofi
Dr. W. Miller
-M cG 0120[440E-ONC-0020-262]
A Ran domized, Phase Ill Trial Comparing CPT-11 (lrinotecan HCI; Camptosar Injection) Cisplatin with Etoposide in
Patients w ith Previously Unt reated, Extensive, Sma ll-Cell Lu ng Cancer
Pharmacia
TERM INATED
Dr. V. Hirsh
-M cG 0121[EP0906A2203]
An Open-Label Phase llA Trial Evaluating the Saf ety and Efficacy of EP0906
in Patients w ith Adv anced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Novartis
Dr. M. Trudeau

WITHDRAWN

-M cG 0122[P02565]
A Phase 11, Open-Label Study of Interfe ron alfa-2b in Combination with SCH 66336 in Patients wit h Metastatic Renal
Cel l Ca ncer
TERM INATED
Schering
Dr.S. Tanguay
-M cG 0123[TNP-470]
A Phase II Study Comparing TNP-470/ Paclitaxel/ Carboplatin Com binations t o Paclitaxel/Carboplatin Alone for
Treatment of Non-Small Cell Lung Cancer
TAP Pharmaceuticals
Dr. A. Langleben
WITHDRAWN BY COMPANY
-M cG 0124[8016411]
A Ran domised, Double-Blind, Placebo Controlled, Mu lticent re, Phase Il l Stu dy of Tarceva Plus Chemotherapy (Cisplatin
and Gemcitabine) Versus Chemotherapy Alone in Patient s wit h Ad vanced (Stage ll lB or IV) Non-Small Cell Lu ng Ca ncer
(NSCLC) Who Have Not Received Prior Chemotherapy
Hoffmann-La Roche
TERM INATED
Dr. V. Hirsh

Active= Open to Enrolhnent

Revised:

2/6/2016
WB

Closed= Closed to Enrolhnent
Terminated= Study Terminated w ith IRB/ hlformation no longer required
Parentheses indicate Principal Itn-estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am

7/58

PDF.Jsvla.ver

9/M016

Page 8 of 58
McG Studies

-McG 0124 RGRoche Sample Repository Resea rch Project in Conjunction wit h Hoffma n-LaRoche Prot ocol Entitled : "A Randomised,
Dou ble-Blind, Placebo Controlled, M ulticentre, Phase Ill Study of Tarceva Pl us Chemotherapy (Cisplatin and
Gemcitabine) Versus Chemot herapy Alone in Patients with Adva nced (Stage lllB or IV) Non-Small Cell Lung Ca ncer
(NSCLC) Who Have Not Received Prior Chemoth erapy"
Hoffmann-La Roche
Dr. V. Hirsh
TERM INATED

-McG 0125-

[04731L/0016]

A Multicent re, Ope n-Label, Randomized, Parallel-Group St udy Evaluating t he Efficacy and Tolerability of ZD0473
Versu s Doxorubicin HCI liposome injection (Doxil™, Caelyx™) in Patient s w ith Refractory Advanced Epithelial Ovarian
Ca ncer in Whom Both Platinum- and Paclitaxel-Based Chemotherapy Regimens Have Failed
AstraZeneca
WITHDRAWN BY COMPANY
Dr. M. Trudeau

-McG 0126-

(5416.035]

A Phase Ill, Randomized, Open-La bel, M ult icenter, Intern ational Stu dy Comparing t he Combination of
SU5416/ lrinotecan/ 5-Fluorouracil/Leucovorin versus lrinotecan/5-Fluorouracil/Leucovorin Alone as First-Line Therapy
of Pat ients With Previously Untre ated Metastatic Colorecta l Cancer
Sugen/ Pharmacia
WITHDRAWN BY COMPANY
Dr. A. Langleben

-McG 0127-

[971-0NC-0028-057]

A Pilot, Open-Label, Ran domized, Comparat ive Study of Exemestane Versus Anast rozole in Post-M enopausal Breast
Ca ncer Patients With Visceral Disease
Pharmacia
TERM INATED
Dr. M. Thirlwell

-McG 0128-

[P01848]

Phase II Multi-Centre Trial of Caelyx™ in Combinat ion with Herceptin® in Her-2 Over-expressi ng Advanced Breast
Ca ncer
Schering
TERM INATED
Dr. L. Panasci

-McG 0129-

[PC4]

A Prospect ive, Ran domised, Cont rolled, Double-Blind, Mu ltinational, M ult i-Cent re Stu dy of G17DT lmmunogen in
Combination Wit h Gemcitabine in Previously Untreated Subjects With Locally Advanced (Nonresect able St age II and
111), Recu rrent Disease Following Primary Resect ion, or M et astatic (Stage IV) Adenocarcinoa of t he Pancreas
Orion
Dr. W.Miller
TERM INATED

-McG 0130-

-See McG 0202 [MP-8899-0104]

A Phase Ill Mult i-Centre Controlled Trial w ith Strat ified Randomization Comparing t he Efficacy of lnterleuki n-2 (IL-2)
plus Histamine Dihydrochloride (HDC) versus IL-2 Alone t o Increase t he Du ration of Survival in Patients with AJCC
St age IV Malignant Melanoma with Hepatic M et astases
Maxim Pharmaceuticals, Inc.
Dr. S. Burdette -Radoux
WITHDRAWN

Active= Open to Enrolhnent

Revised:

2/6/2016
WB

Closed= Closed to Enrolhnent
Terminated= Study Terminated with IRB/ Information no longer required
Parentheses indicate Principal ln\·estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am

8158

PDF.Jsvla.ver

9/M016

Page 9 of 58
McG Studies

-M cG 0131[Biomed 777-CLP-29]
Phase Ill St udy of At amestane Plus Toremif ene Versus Let rozole in Advanced Breast Cancer

BioMedicines, Inc.
Dr. W. Miller

TERM INATED

-M cG 0201[RSR13 RT-012)
A Phase I/II St udy t o Evaluat e t he Safety, Tolerance, and Efficacy of RSR13 Administered t o Pat ients Receivi ng a Course
of Cisplatin and Ra d iat io n Therapy for Locally Advanced Carcinoma of t he Cervix
Allos Thera peut ics, Inc.
TERM INATED
Dr. L. Sou hami/Sylvia Papazian
-M cG 0202[MP-8899-0104)
A Phase 111, M ult i-center Controlled Trial w ith St ra t ifi ed Randomizat ion Comparing t he Efficacy of lnterleu kin -2 (IL-2)
plus Histamine Dihy drochloride (H DC) versus 11-2 Alone to Increase t he Durat ion of Survival in Patients w ith AJ CC Stage
IV M alignant M elanoma w ith Hepat ic Metastasis
Maxim Pharmaceut icals, Inc.
Dr. S. Burdett e-Radoux
COMPANY WITHDRAWN
-M cG 0203[ZXlOl-301)
A Phase Ill Randomized Cont rolled St udy Comparing t he Survival of Patient s wit h Unresectable Hepatocellular
Carci noma (HCC) Treated with THYMITAQ to Pat ients Treated wit h Doxorubicin
WITHDRAWN
Zarix, Inc.
Dr. A. Langleben
-M cG 0204 [GL303]
Randomized Study of Fludarabine and Cyclophosphamide wit h or w ithout Genasense™ (Bcl -2 An t isense

Oligonucleoti de) in Patients w it h Relapsed or Refractory Chronic Lymphocyt ic Leukemia
Genta Incorporated
Dr. C. Shustik

TERM INATED

-M cG 0205[104864A/387]
An Open-Label, M ult icentre, Randomised, Phase Ill Study Comparing Oral Topotecan to Int ravenous Docetaxel in
Pat ients With Pret reat ed Advanced (Stage 1118/ IV) Non-Small Cell Lung Cancer
GlaxoSmithKline
TERM INATED
Dr. V. Hirsh
-M cG 0206[LOR/VIR/ P03/002]
A Phase Ill, Double-Blind, Mu lticenter, Randomized St udy in Chemonaive Patient s w ith Locally Ad vanced or Met astatic
Pancreat ic Cancer to Compare a Combinat ion Therapy of Virulizin® plus Gemcit abine versus Placebo plus Gemcitabine;
Optional Second-Line Therapy may Include Continuation of Viru lizi n® or Placebo, Alone or in Combinatio n w it h 5Fluorouracil
Lorus Therapeut ics Inc.
TERM INATED
Dr. M. Thirlwell
-M cG 0207[GIOV-001)
Actimmune® (Int erferon gamma-lb) in Combination W it h Chemotherapy (Carboplatin/ Pacl itaxel) for First-line
Therapy of Advanced Ovarian or Primary Perit oneal Carcinom a
lntermu ne
TERM INATED

Dr. W. Miller/ Ginet t e

Active= Open to Enrolhnent

Revised:

2/6/2016
WB

Closed= Closed to Enrollment
T er min at ed= Study Ter minated w ith IRB/ Information no longer required
Parentheses indicate Principal ln\·estigator is no longer w~th McGill University

IC!p://sludylib.nelfdoc/8619982/prdocols-lisl---clirical-research-pn:v-am


Related documents


protocols list clinical research program
references arnica breast cancer surgery
lsc htbx note 02022016
detoxifying carcinogens in smokers through
nct00509561
v15n4s57revisiting


Related keywords